February 20, 2026 What Collaboration Makes Possible On a Tuesday afternoon in the fall of 2019, a biostatistician from a pharmaceutical company...
February 16, 2026 Epilepsy disease classification: a community effort to enhance the Mondo Disease Ontology Epilepsy is a diverse group of neurological disorders affecting over 50 million people worldwide.
February 12, 2026 Building the Infrastructure of Hope Medical history is usually written as a chronicle of individual breakthroughs. We learn about Fleming discovering penicillin...
February 10, 2026 The Critical Path Institute Podcast: Electronic Clinical Outcome Assessments in Oncology Research This panel discussion, hosted by C-Path's Electronic Clinical Outcome Assessment Executive Director Scottie Kern...
February 6, 2026 Use of AI within COA linguistic validation and eCOA migration processes: analysis and good practice recommendations While there has been much discussion around the use of Artificial Intelligence (AI) for multilingual translations in other...
February 1, 2026 Turning the Impossible into the POSSIBLE February is Rare Disease Month. It is a time when the global community unites to support the 350 million people worldwide...
January 28, 2026 C-Path’s New Clinical Pharmacology & Therapeutics Publication Highlights Real-World Impact of FDA-Qualified Urine Biomarkers for Earlier Detection of Drug-Induced Kidney Injury C-Path) Predictive Safety Testing Consortium today announced the publication of a new peer-reviewed...
January 27, 2026 Join C-Path’s 2026 Translational Therapeutics Accelerator Funding Opportunities Webinar On Tuesday, January 27, 2026, C-Path's Translational Therapeutics Accelerator will host the 2026 Funding...
January 27, 2026 C-Path’s Translational Therapeutics Accelerator Award Funding Opportunities 2026 C-Path) and the PKD Foundation hosted a webinar to discuss C-Path's Transplant Therapeutics Accelerator (TRxA)...
January 21, 2026 C-Path’s Translational Therapeutics Accelerator Announces 2026 Request for Proposals from Academic Investigators TUCSON, Ariz., January 21, 2026 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator today...
